Severe hepatic failure related to nevirapine treatment

Clinical Infectious Diseases

Volumn 29, Issue 2, 1999, Pages 455-456

  Cattelan, Anna Maria ^a,b   Erne, Elke ^b   Salatino, Aureliano ^b   Trevenzoli, Marco ^b   Carretta, Giovanni ^b   Meneghetti, Francesco ^b   Cadrobhi, Paolo ^b  

^a Department of Infectious Diseases ^*  (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; DIDANOSINE; LAMIVUDINE; NEVIRAPINE; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LIVER FAILURE; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN MANIFESTATION;

EID: 0032770948     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520242     Document Type: Article

References (4)

1. 1. Carr A, Vella S, de Jong MD, et al. A controlled trial of nevirapine plus zidovudine alone in p24 antigenic HIV-infected patients. AIDS 1996; 10:635-41.
2. 2. Montaner JS, Reiss P, Cooper D, et al. A randomized double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. JAMA 1998;279:930-7.
3. 3. Havlir D, Cheeseman SH, McLaughlin M, et al. High dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis 1995;171:537-45.
4. 4. Warren KJ, Boxwell DE, Kim NY, Drolet BA. Nevirapine-associated Stevens-Johnson syndrome. Lancet 1998;351:567.